Funding Agency: NIH/NIAID
Role on Project: Co-Principal Investigator
Budget Period: 09/30/2018 – 09/29/2023
Total Funding: $ 8,500,000
The goal of this study is to develop a more effective and longer-lasting vaccine against pertussis, more commonly known as “whooping cough.” We will add bacterial outer membrane vesicles to DTaP, an existing vaccine against three deadly diseases caused by bacteria: diphtheria, tetanus and pertussis. We'll use this to evaluate the OMV-based vaccine’s safety and effectiveness in animal models paving the way for potential clinical studies.